Beiträge

Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ

Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence

A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes

Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein

T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine

Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus

Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein

Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells

Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory

Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit